13:30 – 13:35
Opening Remarks
13:35 – 13:50
A Newco of Taiwan and US - AltruBio, Inc.
- Judy Chou, President & CEO, AltruBio Inc.
13:50 – 15:00
Roadshow
- 1E Therapeutics
- aceRNA Technologies
- ACRO Biomedical
- Alar Pharmaceuticals
- AP Biosciences
- APRINOIA Therapeutics
- Biomea Fusion
- Foresee Pharmaceuticals
- GenomeFrontier Therapeutics
- Handa Pharmaceuticals
15:00 – 15:30
Panel Discussion 1: Business Development & Licensing - Critical Exit Strategy for New Venture
Moderator:
Panelists:
- Jenny Hsiung, Director, Business Development & Acquisitions, AbbVie
- Chung-Ming (CM) Hsieh, Vice President, Research Protein Therapeutics, Gilead Sciences
- Hsin-Pei Shih, Senior Director, Search and Evaluation, Rare Disease Business Development, Novo Nordisk
15:30 – 16:50
Roadshow
- Lin Bioscience
- OBI Pharma
- Oncomatryx Biopharma
- Pharmosa Biopharm
- Pilatus Biosciences
- Rakuten Medical
- Rege Nephro
- Steminent Biotherapeutics
- Sunhawk Vision Biotech
- T-E Meds
- TLC BioSciences
16:50 – 17:20
Panel Discussion 2: Global Investment Trends
Moderator:
Panelists:
- Charles Lin, Principal, Illumina Ventures
- Alva Chen, Managing Director, Healthcare, VMS Group
- Lori Hu, Managing Director, Vertex Ventures HC
- John Tsai, Executive Partner, Syncona
17:20 - 17:55
Roadshow
- AdipoSeeds
- ARCE Therapeutics
- CK Life Sciences Int'l
- Ever Supreme Bio Technology
- Nano Targeting & Therapy Biopharma
- OBIGEN Pharma
- Taiwan Bio Therapeutics
- Trust Bio-sonics
18:30 – 20:30